World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
9862
World Ranking
3752
National Ranking
258

Halvard Bonig publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Halvard Bonig sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 300 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Halvard Bonig D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Halvard Bonig sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Halvard Bonig is affiliated with Goethe University Frankfurt in Germany and has contributed extensively to the field of medicine, with a particular focus on oncology, immunology, hematology, genetics, and molecular biology. Their research primarily revolves around CAR-T cell therapy, hematopoietic stem cell transplantation, immune cell function and interaction, virus-based gene therapy, acute myeloid leukemia, T-cell and B-cell immunology, and mesenchymal stem cell research.

The scientist has published in a variety of specialized venues, with frequent contributions appearing in:

  • Blood
  • Journal of Translational Medicine
  • Bone Marrow Transplantation
  • Cells
  • Klinische Pädiatrie

Halvard Bonig's recent publications include:

  • Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA), 2021, Annals of Oncology
  • CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma, 2021, Gene Therapy
  • Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia, 2021, Blood
  • Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4, 2020, Frontiers in Immunology
  • Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma, 2021, Blood

Their frequent collaborators include:

  • Peter Bader
  • Erhard Seifried
  • Evelyn Ullrich
  • Eva Rettinger
  • Andrea Jarisch

The focus of Halvard Bonig's work in CAR-T cell therapy research is reflected by a substantial number of publications, with 80 dedicated to this topic alone. Other significant research areas include hematopoietic stem cell transplantation with 54 related publications and immune cell function and interaction with 50 publications.

In summary, the research profile centers on advanced therapeutic approaches in oncology and hematology, emphasizing cellular therapies and immune system interactions. The body of work spans molecular biology techniques and clinical applications in hematologic malignancies and immune response modulation.

Best Publications

  • Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

    Ibrahim Yakoub-Agha;Christian Chabannon;Peter Bader;Grzegorz W. Basak

  • Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

    Kurt Schönfeld;Christiane Sahm;Congcong Zhang;Sonja Naundorf

  • Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.

    Wolfgang Miesbach;Karina Meijer;Michiel Coppens;Peter Kampmann

  • Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab

    Halvard B. Bonig;Annette Wundes;Kai-Hsin Chang;Sylvia Lucas

  • CAR T-cells targeting FLT3 have potent activity against FLT3 - ITD + AML and act synergistically with the FLT3-inhibitor crenolanib

    Hardikkumar Jetani;Irene Garcia-Cadenas;Thomas Nerreter;Simone Thomas

  • Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals.

    Kai Uwe Chow;Beate Luxembourg;Erhard Seifried;Halvard Bonig

  • Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

    M Neuenhahn;J Albrecht;M Odendahl;F Schlott

  • Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

    Patrick Wuchter;Karen Bieback;Hubert Schrezenmeier;Martin Bornhäuser

  • CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.

    Sabrina Prommersberger;Michael Reiser;Michael Reiser;Julia Beckmann;Sophia Danhof

  • The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization

    Thalia Papayannopoulou;Gregory V. Priestley;Halvard Bonig;Betty Nakamoto

  • Epigenetic Regulation of Endothelial Lineage Committed Genes in Pro-Angiogenic Hematopoietic and Endothelial Progenitor Cells

    kisho ohtani;Georgios J. Vlachojannis;Masamichi Koyanagi;Jes Niels Boeckel

  • Hematopoietic stem cell mobilization: updated conceptual renditions.

    H Bonig;T Papayannopoulou

  • Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey.

    Zyrafete Kuçi;Halvard Bönig;Hermann Kreyenberg;Milica Bunos

  • Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.

    Yao Te Hsieh;Eun Ji Gang;Huimin Geng;Eugene Park

  • Hoxa9 and Meis1 cooperatively induce addiction to Syk signaling by suppressing miR-146a in acute myeloid leukemia.

    S Mohr;C Doebele;F Comoglio;T Berg

  • Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines.

    Halvard Bonig;Gregory V. Priestley;Thalia Papayannopoulou

  • Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).

    Peter Bader;Zyrafete Kuçi;Shahrzad Bakhtiar;Oliver Basu

  • Concise Review: CXCR4/CXCL12 Signaling in Immature Hematopoiesis—Lessons From Pharmacological and Genetic Models

    Darja Karpova;Halvard Bonig

  • High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation

    L Hempel;D Körholz;P Nussbaum;H Bönig

  • Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies

    Paulina Nowakowska;Paulina Nowakowska;Annette Romanski;Annette Romanski;Nicole Miller;Marcus Odendahl

  • Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device.

    Peter Reinhardt;Susanne Brauninger;Heike Bialleck;Kristin Thorausch

Frequent Co-Authors

Erhard Seifried
Erhard Seifried German Red Cross
Peter Bader
Peter Bader Goethe University Frankfurt
Thomas Klingebiel
Thomas Klingebiel Goethe University Frankfurt
Thalia Papayannopoulou
Thalia Papayannopoulou University of Washington
Torsten Tonn
Torsten Tonn TU Dresden
Hubert Serve
Hubert Serve Goethe University Frankfurt
Winfried S. Wels
Winfried S. Wels Goethe University Frankfurt
Peter Lang
Peter Lang University of Bern
Hermann Einsele
Hermann Einsele University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, many of which benefit from complementary nursing qualifications. For those interested in advancing quickly, accelerated nurse practitioner programs offer an efficient pathway to becoming a healthcare provider with a focus on patient care and medical research.

If you are coming from a non-nursing background, online options like online RN programs for non nurses provide a flexible route to earn a Registered Nurse degree, which is valuable for careers bridging immunology and clinical practice.

For those seeking quicker entry points, exploring some of the easiest accelerated nursing programs to get into can help jumpstart a nursing career, which complements immunology expertise in hospitals and research settings.

Additionally, LPN schools easy to get into provide accessible foundational training for practical nursing roles, often serving as a stepping stone toward more advanced positions that interact with immunological sciences and patient care.

Best Scientists Citing Halvard Bonig

Trending Scientists

Recently Published Articles